You are here

  • Home
  • Archive
  • Volume 72, Issue 6
  • Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

Article Text

Article menu
Download PDFPDF
Electronic pages
Letter
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
  1. Claire-Louise Murphy,
  2. Eithne Murphy,
  3. Trevor Duffy,
  4. Miriam O'Sullivan,
  5. Maurice Barry
  1. Department of Rheumatology, Connolly Hospital, Dublin, Ireland
  1. Correspondence to Dr Claire-Louise Murphy, Department of Rheumatology, Connolly Hospital, Dublin, Blanchardstown, Dublin 15, Dublin15, Ireland; clairelouisem{at}gmail.com

http://dx.doi.org/10.1136/annrheumdis-2013-203637

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the paper regarding the efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.1 We note the exclusion criteria included secondary knee osteoarthritis. On review of the results section, it appears that many of the patients, the randomised and the intention-to-treat groups, for example, the strontium 1 g/day group, strontium 2 g/day group and placebo group, were either overweight or …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles